Skip to main content
MTLSMaterialise NVHold5.0·$6.49
HoldModerate Confidence
Investment thesis

Materialise has beaten earnings in 4 of 4 quarters with excellent cash conversion, but growth is weak, estimates are being trimmed, and momentum is soft, leaving about 18% analyst-target upside.

Thesis pillars

  • Estimates Being Cut→Stable
  • Perfect Earnings Beat Streak→Stable
  • Strong Cash Conversion→Stable
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Nov 1, 2026

Full reasoning →

Open full analysis

Materialise NV (MTLS) Stock Analysis

HoldVALUE-TRAP 1/5ValueQualityModerate Confidence

Technology · Software - Application

Hold if already holding. Not a fresh buy at $6.49, but acceptable to hold if already in. Reason: Market cap $370M below $400M minimum.

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The... Read more

$6.49+28.7% A.UpsideScore 5.0/10#103 of 116 Software - Application
QualityF-score8 / 9FCF yield7.20%
Stop $6.16Analyst target $8.35(−15% haircut)A.R:R 2.0:1
Analyst consensus$9.83+51.4%3 analysts with price targets
$8.35Analyst target
$6.49price
$9.83mean
$13

Hold if already holding. Not a fresh buy at $6.49, but acceptable to hold if already in. Reason: Market cap $370M below $400M minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $370M below $400M minimum. Not in investable universe. Score 5.0/10, moderate confidence.

Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 94d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

No fresh coverage since Oct 29, 2026

Recent Developments — Materialise NV

Latest item Oct 29, 2026 · Generated 2026-11-16T12:02:30Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Feb 18, 202794d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Market cap $370M below $400M minimum

Key Metrics

P/E (TTM)25.0
P/E (Fwd)25.1
Mkt Cap$370M
EV/EBITDA11.7
Profit Mgn4.6%
ROE5.0%
Rev Growth2.1%
Beta1.30
DividendNone
Analysts with ratings9

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.00neutral

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
3.0

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Volume
0.0
Obv
1.0
Macd
2.1
Ma Position
4.0
Rsi
8.4
Oversold in uptrend (RSI 24)Volume distribution (falling OBV)Above 200-day MA
GatesMomentum 3.1<4.5A.R:R 2.0 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 94d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
24 · Oversold
↓ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $6.35Resistance $8.78

Price Targets

$6
$8
A.Upside+28.7%
A.R:R2.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeSteady

Risk Alerts

! Market cap $370M below $400M minimum
! momentum at 3.1 (below the engine's 4.5 threshold)

Earnings

B
B
B
B
4/4 beats
Next Earnings2027-02-18 (94d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MTLS stock a buy right now?

Hold if already holding. Not a fresh buy at $6.49, but acceptable to hold if already in. Reason: Market cap $370M below $400M minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $370M below $400M minimum. Not in investable universe. Analyst target $8.35 (+28.7%), stop $6.16 (−5.4%), A.R:R 2.0:1. Score 5.0/10, moderate confidence.

What is the MTLS stock price target?

Analyst target: $8.35 (+28.7% upside). Analyst target $8.35 (+28.7%), stop $6.16 (−5.4%), A.R:R 2.0:1. Stop-loss: $6.16.

What are the risks of investing in MTLS?

Market cap $370M below $400M minimum.

Is MTLS overvalued or undervalued?

Materialise NV trades at a P/E of 25.0 (forward 25.1). TrendMatrix value score: 6.8/10. Verdict: Hold.

What do analysts say about MTLS?

9 analysts rate MTLS, with a consensus score of 4.1/5. 3 analysts publish price targets averaging $10.

What does Materialise NV do?Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas,...

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Related stocks: DAVE (Dave Inc.) · VTEX (VTEX) · DCBO (Docebo Inc.) · MITK (Mitek Systems, Inc.) · GRND (Grindr Inc.)
Home › Stocks › MTLS

Latest news

Latest News

Stock Titan19d ago
Yahoo Finance19d agoEarnings
Yahoo Finance19d agoEarnings
StocksToTrade19d ago
Benzinga19d agoEarnings
Grafa.com19d agoEarnings
Www.marketscreener.com19d agoEarnings
MarketBeat19d agoEarnings
GuruFocus19d agoEarnings
Investing.com19d ago
Scanx.trade20d ago
Yahoo Finance27d ago
Yahoo Finance18d ago
TradingView22d ago
Www.marketscreener.com21d ago
Https://www.dars.gov.et/21d ago
TradingView24d ago
Benzinga19d ago
Benzinga19d ago
Benzinga19d agoEarnings
Loading more...